Virtus ETF Advisers LLC Alx Oncology Holdings Inc Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Alx Oncology Holdings Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 10,920 shares of ALXO stock, worth $19,983. This represents 0.01% of its overall portfolio holdings.

Number of Shares

10,920

Previous 10,726 1.81%

Holding current value

$19,983

Previous $64,000 70.31%

% of portfolio

0.01%

Previous 0.03%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$1.81 - $8.13 $351 - $1,577	194 Added 1.81%	10,920 $19,000
Q2 2024 Aug 14, 2024	BUY	$5.84 - $17.56 $24,294 - $73,049	4,160 Added 63.36%	10,726 $64,000
Q1 2024 May 15, 2024	SELL	$10.95 - $16.79 $4,960 - $7,605	-453 Reduced 6.45%	6,566 $73,000
Q4 2023 Feb 15, 2024	SELL	$4.81 - $15.38 $17,835 - $57,029	-3,708 Reduced 34.57%	7,019 $104,000
Q3 2023 Nov 07, 2023	SELL	$4.19 - $7.35 $4,470 - $7,842	-1,067 Reduced 9.05%	10,727 $51,000
Q2 2023 Aug 14, 2023	BUY	$4.37 - $9.56 $12,126 - $26,529	2,775 Added 30.77%	11,794 $88,000
Q1 2023 May 15, 2023	SELL	$4.52 - $11.71 $15,661 - $40,575	-3,465 Reduced 27.76%	9,019 $40,000
Q4 2022 Feb 14, 2023	SELL	$9.51 - $12.95 $31,116 - $42,372	-3,272 Reduced 20.77%	12,484 $140,000
Q3 2022 Nov 14, 2022	BUY	$8.23 - $15.14 $946 - $1,741	115 Added 0.74%	15,756 $151,000
Q2 2022 Aug 12, 2022	BUY	$5.89 - $19.46 $54,046 - $178,564	9,176 Added 141.93%	15,641 $127,000
Q1 2022 May 16, 2022	SELL	$13.65 - $22.06 $5,173 - $8,360	-379 Reduced 5.54%	6,465 $109,000
Q4 2021 Feb 14, 2022	BUY	$21.49 - $74.4 $71,303 - $246,859	3,318 Added 94.1%	6,844 $147,000
Q3 2021 Nov 15, 2021	SELL	$52.51 - $80.91 $10,081 - $15,534	-192 Reduced 5.16%	3,526 $260,000
Q2 2021 Aug 10, 2021	SELL	$52.2 - $75.23 $2,088 - $3,009	-40 Reduced 1.06%	3,718 $203,000
Q1 2021 May 17, 2021	BUY	$62.84 - $87.68 $4,398 - $6,137	70 Added 1.9%	3,758 $277,000
Q4 2020 Feb 12, 2021	BUY	$34.11 - $112.26 $125,797 - $414,014	3,688 New	3,688 $318,000

Others Institutions Holding ALXO

# of Institutions

101

Shares Held

39.7M

Call Options Held

134K

Put Options Held

17.4K

View Full List

About ALX ONCOLOGY HOLDINGS INC

Ticker ALXO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,747,100
Market Cap $74.6M
Description
ALX Oncology Holdings Inc., a clinical-stage immuno-oncology company, focuses on developing therapies for patients fighting cancer. Its lead product candidate is ALX148, a CD47 blocking therapeutic that is in Phase 1b/2 clinical trial used for the treatment of myelodysplastic syndromes; and for the treatment of acute myeloid leukemia and non-Hod...

More about ALXO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Alx Oncology Holdings Inc Transaction History